Open AccessCapecitabine-Induced Takotsubo Cardiomyopathy: A Case Report
Author(s) -
Prarthna V Bhardwaj,
V. K. Chaubey,
Ashequl Islam
Publication year - 2019
Publication title -
the permanente journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/18.245
Subject(s) - capecitabine , medicine , cardiomyopathy , chest pain , cardiology , cardiac catheterization , incidence (geometry) , cardiotoxicity , heart failure , cancer , chemotherapy , colorectal cancer , physics , optics
The medication 5-fluorouracil is known to cause cardiotoxic effects (with an incidence ranging from 5% to 18%), such as rhythm abnormalities and cardiomyopathies, including takotsubo cardiomyopathy. Capecitabine, an oral prodrug of 5-fluorouracil, has rarely been reported to cause cardiotoxic effects compared with its parent drug.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom